Occurrence and prediction of flare after tapering of TNF inhibitors in patients with axial spondyloarthritis.
Patients with axial spondyloarthritis (axSpA) in clinical remission tapered Tumor Necrosis Factor inhibitor (TNFi) therapy according to a clinical guideline. During 2-years’ follow-up, we aimed to investigate flare...
Read More